Survival of Human Immunodeficiency Virus Type 1 After Rinsing Injection Syringes with Different Cleaning Solutions

References

• Abdala N., Gleghorn A., Carney J. M., Heimer R. Use of bleach to disinfect HIV-1 contaminated syringes. Am. Clin. Lab. 2001; 20(6)26–28, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Abdala N., Gleghorn A. A., Carney J. M., Heimer R. Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users. J. Acquir. Immune Defic. Syndr. 2001; 28(5)487–494, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Abdala N., Reyes R., Carney J. M., Heimer R. Survival of HIV-1 in syringes: effects of temperature during storage. Subst. Use Misuse 2000; 35(10)1369–1383, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Abdala N., Stephens P. C., Griffith B. P., Heimer R. Survival of HIV-1 in syringes. J. Acquir. Immune Defic. Syndr. 1999; 20(1)73–80
   Google Scholar
• Anonymous. Knowledge and practices among injecting-drug users of bleach use for equipment disinfection—New York City, 1993. MMWR Morbidity & Mortality Weekly Report 1994; 43(24)445–446
   Google Scholar
• Aranda-Anzaldo A., Viza D., Busnel R. G. Chemical inactivation of human immunodeficiency virus in vitro. J. Virol. Methods 1992; 37(1)71–81, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Carlson R. G., Siegal H. A., Wang J. C., Falck R. S. Attitudes toward needle sharing among injection drug users—combining qualitative and quantitative research methods. Human Organization 1996; 55(3)361–369
   Web of Science ®Google Scholar
• CDC. Recommendations for prevention of HIV transmission in health-care settings. USPHS Centers for Disease Control. NY. State J. Med. 1988; 88(1)25–31
   PubMedGoogle Scholar
• CDC. Use of bleach for disinfection of drug injection equipment. MMWR 1993; 42(21)418–419
   PubMedGoogle Scholar
• Des Jarlais D. C. Prospects for a public health perspective on psychoactive drug use. Am. J. Public Health 2000; 90(3)335–337, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Des Jarlais D. C., Friedman S. R. Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. Public Health Rep. 1998; 113(suppl 1)182–188, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Druce J. D., Jardine D., Locarnini S. A., Birch C. J. Susceptibility of HIV to inactivation by disinfectants and ultraviolet light. J. Hosp. Infect. 1995; 30(3)167–180, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Fabian T. M., Walker S. E. Stability of sodium hypochlorite solutions. Am. J. Hosp. Pharm 1982; 39(6)1016–1017, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Favero M. S. Forum: disinfection & sterilization procedures used in hospitals in the U.S. Asepsis 1994; 16(4)16–19, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Floyd R. HIV-1 inactivation by bleach. Journal of Acquired Immune Deficiency Syndromes 1994; 7(2)204–205, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Flynn N., Jain S., Keddie E. M., Carlson J. R., Jennings M. B., Haverkos H. W., Nassar N., Anderson R., Cohen S., Goldberg D. In vitro activity of readily available household materials against HIV-1: is bleach enough?. J. Acquir. Immune Defic. Syndr. 1994; 7(7)747–753, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Gleghorn A. A., Doherty M. C., Vlahov D., Celentano D. D., Jones T. S. Inadequate bleach contact times during syringe cleaning among injection drug users. Journal of Acquired Immune Deficiency Syndromes 1994; 7(7)767–772, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Grund J. P., Stern L. S. Residual blood in syringes: size and type of syringe are important. AIDS 1991; 5(12)1532–1533, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Grund J. P., Stern L. S., Kaplan C. D., Adriaans N. F., Drucker E. Drug use contexts and HIV-consequences: the effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. Br. J. Addict. 1992; 87(3)381–392, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hansen P. J. Chemical inactivation of HIV on surfaces. BMJ 1989; 299(6693)260, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Heimer R. Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond. Public Health Rep. 1998; 113(suppl 1)67–74, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Heimer R., Khoshnood K., Bigg D., Guydish J., Junge B. Syringe use and reuse: effects of syringe exchange programs in four cities. J. Acquir. Immune Defic. Syndr. 1998; 18(suppl 1)S37–S44
   Google Scholar
• Hollinger F. B., Bremer J. W., Myers L. E., Gold J. W., McQuay L. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories. J. Clin. Microbiol. 1992; 30(7)1787–1794, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Jamner M. S., Corby N. H., Wolitski R. J. Bleaching injection equipment: influencing factors among IDUs who share. Subst. Use Misuse 1996; 31(14)1973–1993, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Johnson B. R., Remeikis N. A. Effective shelf-life of prepared sodium hypochlorite solution. J. Endod. 1993; 19(1)40–43, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Latkin C. A., Mandell W., Vlahov D., Knowlton A. R., Oziemkowska M., Celentano D. D. Self-reported reasons for needle sharing and not carrying bleach among injection drug users in Baltimore, Maryland. J. Drug Issues 1995; 25(4)865–870
   Web of Science ®Google Scholar
• Lavelle G. C., Gubbe S. L., Neveaux J. L., Bowden B. J. Evaluation of an antimicrobial soap formula for virucidal efficacy in vitro against human immunodeficiency virus in a blood-virus mixture. Antimicrobial Agents & Chemotherapy 1989; 33(12)2034–2036
   PubMedGoogle Scholar
• Longshore D., Bluthenthal R. N., Stein M. D. Needle exchange program attendance and injection risk in Providence, Rhode Island. AIDS Educ. Prev. 2001; 13(1)78–90, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Longshore D., Stein J. A., Anglin M. D. Ethnic differences in the psychosocial antecedents of needle/syringe disinfection. Drug Alcohol Depend. 1996; 42(3)183–196, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Mandell W., Kim J., Latkin C., Suh T. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. Am. J. Drug Alcohol Abuse 1999; 25(1)117–127, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McCoy C. B., Rivers J. E., McCoy H. V., Shapshak P., Weatherby N. L., Chitwood D. D., Page J. B., Inciardi J. A., McBride D. C. Compliance to bleach disinfection protocols among injecting drug users in Miami. J. Acquir. Immune Defic. Syndr. 1994; 7(7)773–776, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Montefiori D. C., Robinson W. E., Jr., Modliszewski A., Mitchell W. M. Effective inactivation of human immunodeficiency virus with chlorhexidine antiseptics containing detergents and alcohol. J. Hosp. Infect. 1990; 15(3)279–282, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Myers L. E., McQuay L. J., Hollinger F. B. Dilution assay statistics. J. Clin. Microbiol. 1994; 32(3)732–739, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Needle R. H., Coyle S. L., Normand J., Lambert E., Cesari H. HIV prevention with drug-using populations—current status and future prospects: introduction and overview. Public Health Rep. 1998; 113(suppl 1)4–18, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Nicoletti A. M., Magalhaes F. J. Influence of the container and environmental factors in the stability of sodium hypochlorite. Bol Oficina Sanit Panam. 1996; 121(4)301–309
   PubMedGoogle Scholar
• NIDA. NIDA/CSAT/CDC Workshop on the use of bleach for the decontamination of drug injection equipment. Proceedings. Baltimore, Maryland, February 9–10, 1994. J. Acquir. Immune Defic. Syndr. 1994; 7(7)741–776
   Google Scholar
• Noda M., Matsuda S., Kobayashi M. Virucidal activity of disinfectants: virucidal activities of disinfectants on some viruses coated on several materials and its durability. Kansenshogaku Zasshi. J. Japan Assoc. Infect Dis. 2000; 74(12)1023–1031
   PubMedGoogle Scholar
• Piskin B., Turkun M. Stability of various sodium hypochlorite solutions. J. Endod. 1995; 21(5)253–255, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rietmeijer C. A., Kane M. S., Simons P. Z., Corby N. H., Wolitski R. J., Higgins D. L., Judson F. N., Cohn D. L. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted, community-level HIV prevention program. AIDS 1996; 10(3)291–298, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Romanelli F., Smith K. M., Pomeroy C. Reducing the transmission of HIV-1: needle bleaching as a means of disinfection. J. Am. Pharmaceutl Assoc. 2000; 40(6)812–817
   Google Scholar
• Rutala W. A., Barbee S. L., Aguiar N. C., Sobsey M. D., Weber D. J. Antimicrobial activity of home disinfectants and natural products against potential human pathogens. Infect Contr. & Hosp. Epidemiol. 2000; 21(1)33–38
   PubMed Web of Science ®Google Scholar
• Rutala W. A., Cole E. C., Thomann C. A., Weber D. J. Stability and bactericidal activity of chlorine solutions. Infect Control Hosp. Epidemiol. 1998; 19(5)323–327, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sattar S. A., Springthorpe V. S. Survival and disinfectant inactivation of the human immunodeficiency virus: a critical review. Rev. Infect Dis. 1991; 13(3)430–447, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Scott W. A., Brambilla D., Siwak E., Beatty C., Bremer J., Coombs R. W., Farzadegan H., Fiscus S. A., Hammer S. M., Hollinger F. B., Khan N., Rasheed S., Reichelderfer P. S. Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating laboratories of the AIDS clinical trials group. J. Clin. Microbiol. 1996; 34(9)2312–2315, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Shapshak P., McCoy C. B., Shah S. M., Page J. B., Rivers J. E., Weatherby N. L., Chitwood D. D., Mash D. C. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. J. Acquir. Immune Defic. Syndr. 1994; 7(7)754–759, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Shikani A. H., St Clair M., Domb A. Polymer-iodine inactivation of the human immunodeficiency virus. J. Am. Coll. Surg. 1996; 183(3)195–200, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Shimakoshi Y., Sano K., Nakano T., Nakamura T., Ohshiba S., Katsu K., Nakai M. A micro-suspension-test for evaluation of disinfectants against human immunodeficiency virus. Kansenshogaku Zasshi 1995; 69(5)532–538, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Titus S., Marmor M., Des Jarlais D., Kim M., Wolfe H., Beatrice S. Bleach use and HIV seroconversion among New York City injection drug users. J. Acquir. Immune Defic. Syndr. 1994; 7(7)700–704, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Tjotta E., Hungnes O., Grinde B. Survival of HIV-1 activity after disinfection, temperature and pH changes, or drying. J. Med. Virol 1991; 35(4)223–227, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• van Bueren J. Methodology for HIV disinfectant testing. Journal of Hospital Infection 1995; 30: 383–388, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Vlahov D., Astemborski J., Solomon L., Nelson K. E. Field effectiveness of needle disinfection among injecting drug users. J. Acquir. Immune Defic. Syndr. 1994; 7(7)760–766, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Vlahov D., Munoz A., Celentano D. D., Cohn S., Anthony J. C., Chilcoat H., Nelson K. E. HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland. Epidemiology 1991; 2(6)444–446, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Weber D. J., Barbee S. L., Sobsey M. D., Rutala W. A. The effect of blood on the antiviral activity of sodium hypochlorite, a phenolic, and a quaternary ammonium compound. Infect. Control Hosp. Epidemiol. 1999; 20(12)821–827, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wood A., Payne D. The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses. J. Hosp. Infect. 1998; 38(4)283–295, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar